Searching for "Beijing Genomics Institute"
Found 19 result(s)
Showing 4 article(s). 15 more available to premium subscribers.
Shenzhen-based genetic testing company BGI Genomics has announced that the company will IPO on the Shenzhen stock exchange tomorrow, seeking to raise approximately RMB 547 mln, floating no more than 10.02% of the company's equity. Read More
Chinese internet company Baidu's (Nasdaq: BIDU) cloud services division Baidu Cloud has set up an online platform called "BGI BRCA Online" for genomics research company BGI, which will provide gene sequencing data analysis for research and applications into hereditary breast and ovarian cancers. Read More
Beijing-based Geneplus Technology, operator of online gene testing and analysis service Gene Plus, announced recently that it has completed RMB 200 mln in Series A funding led by Beijing Genomics Institute with participation by Volcanics Venture and Shenzhen-based Green Pine Capital Partners. Read More
Shenzhen-based healthcare data platform and artificial intelligence technology developer iCarbonX Smart Technology has announced it completed RMB 1 bln (roughly USD 150 mln) in Series A funding from a group of investors including Chinese internet and mobile services firm Tencent (0700.HK), Tianjin-based cell and gene engineering business Zhongyuan Union Cell & Gene Engineering (Vcan Bio) (600645.SH), and others. Read More